RNS Number : 9245R
Coro Energy PLC
06 March 2023

6 March 2023


Coro Energy Plc

("Coro" or the "Company")


Intended Non-Executive Director Appointment


Coro Energy Plc, the South East Asian energy company with a natural gas and clean energy portfolio is pleased to announce the intended appointment of Naheed Memon as a non-executive director of the Company.  Naheed is a dual UK and Pakistani national who has worked extensively across the private and public sector in both Pakistan and internationally.   She routinely rotates between Islamabad, Dubai and London and is Chief Executive of AIM quoted Oracle Power plc.


A further announcement in respect of Naheed Memon's intended appointment to the Board of the Company will be made in due course.


James Parsons, Coro's Chairman, commented:


"I look forward to welcoming Naheed to the Board and to her contribution across the business, including our regional business development."


For further information please contact:

Coro Energy plc

James Parsons, Executive Chairman

Ewen Ainsworth, Chief Financial Officer


Via Vigo Consulting Ltd




Cenkos Securities plc (Nominated Adviser)

Adrian Hadden

Ben Jeynes



Tel: 44 (0)20 7397 8900

Vigo Consulting (IR/PR Advisor)

Patrick d'Ancona

Charlie Neish


Tel: 44 (0)20 7390 0230

WH Ireland (Broker)

Harry Ansell

Katy Mitchell



  Tel: 44 (0)20 7220 1670 / 44 (0)113 946 618


Gneiss Energy Limited (Financial Advisor)

Jon Fitzpatrick

Doug Rycroft


  Tel: 44 (0)20 3983 9263





This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.